Equity Capital Markets

Company · CIK 1812364

Relay Therapeutics, Inc.

CIK1812364 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedRLAY (Nasdaq)
First annual or quarterly report2020-08-27

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-281308
ShelfEffective
 2024-08-062026-08-066
333-258768
ShelfEffective
 2021-08-122022-09-135
333-255583
Registered companyFinal prospectus
 2021-04-282021-05-063
333-239412
IPOFinal prospectus
 2020-06-242020-07-167

Filings

22
FiledFilingRegistrationAccession
2026-08-06424B5Shelf takedown 333-2813080001193125-26-338292
2026-05-21424B5Shelf takedown 333-2813080001193125-26-234428
2026-05-19424B5Shelf takedown 333-2813080001193125-26-231113
2024-09-11424B5Shelf takedown 333-2813080001193125-24-217294
2024-09-09424B5Shelf takedown 333-2813080001193125-24-215956
2024-08-06S-3ASRShelf registered 333-2813080001193125-24-194962
2022-09-13424B5Shelf takedown 333-2587680001193125-22-243800
2022-09-12424B5Shelf takedown 333-2587680001193125-22-242425
2021-10-13424B5Shelf takedown 333-2587680001564590-21-050744
2021-10-12424B5Shelf takedown 333-2587680001564590-21-050582
2021-08-12S-3ASRShelf registered 333-2587680001193125-21-244873
2021-05-06EFFECTDeclared effective 333-2555839999999995-21-001832
2021-05-06424B4Final prospectus 333-2555830001193125-21-153334
2021-04-28S-1Registration filed 333-2555830001193125-21-137130
2020-07-16424B4Final prospectus 333-2394120001193125-20-194016
2020-07-15EFFECTDeclared effective 333-2394129999999995-20-001810
2020-07-15S-1/AAmendment 333-2394120001193125-20-193278
2020-07-15S-1/AAmendment 333-2394120001193125-20-192936
2020-07-14S-1/AAmendment 333-2394120001193125-20-192676
2020-07-09S-1/AAmendment 333-2394120001193125-20-190069
2020-06-24S-1Registration filed 333-2394120001193125-20-177746
2020-05-22DRSDraft made public 377-031850000950123-20-005492

All filings of this company · CSV